Civilization 7 is out and developer Firaxis is already working to address its 'mixed' user review rating on Steam. But ...
Manny Pacquiao is set to join Netflix‘s upcoming Physical: 100 spin-off, Physical: Asia. The streamer announced that the boxing legend will serve as the Philippine representative in the ...
Premiering March 7, When Life Gives You Tangerines will feature popular singer-actress IU alongside Park Bo-gum. In April, Resident Playbook, a spin-off from hit series Hospital Playlist, will follows ...
Now titled Physical: Asia and premiering in the fourth quarter of this year, the series scales up its quest for the ultimate physique beyond individual matchups — unleashing a full-blown ...
Manny Pacquiao is joining hit survival reality competition show "Physical: Asia!" Netflix made the announcement on Tuesday with photos of the boxing legend with his wife, Jinky Paquiao, at the airport ...
Future boxing Hall of Famer Manny Pacquiao, now a popular figure in Korean and Japanese media post-retirement, reappears with a landmark involvement in South Korean reality show 'Physical ...
We have selected seven stories from the SCMP’s coverage of Asia over the past week that resonated with our readers and shed light on topical issues. If you would like to see more of our ...
This is why football fans are perplexed by the Kansas City Chiefs, and frustrated with them continuing to win. Kansas City didn’t play its best game in the divisional round of the NFL playoffs.
Physical: Asia. This high-stakes team competition features top athletes representing their countries. Set to premiere in late 2025, Physical: Asia adds another chapter to Pacquiao’s storied career.
Among the Korean tentpole projects previously announced by Netflix, Revelations will mark a film collaboration between Train to Busan director Yeon Sang-ho and Roma filmmaker Alfonso Cuarón. The ...
Fierce Pharma Asia—AbbVie's $1B pact with Simcere; Takeda's launch map; Samsung Bio's growth plans
As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion deal for the Chinese biopharma's phase 1 T-cell engager. Later during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results